AC Immune (ACIU) Equity Ratio (2016 - 2025)
Historic Equity Ratio for AC Immune (ACIU) over the last 10 years, with Q4 2024 value amounting to 0.49.
- AC Immune's Equity Ratio fell 4466.97% to 0.49 in Q4 2024 from the same period last year, while for Dec 2024 it was 0.49, marking a year-over-year decrease of 4466.97%. This contributed to the annual value of 0.49 for FY2024, which is 4466.97% down from last year.
- Per AC Immune's latest filing, its Equity Ratio stood at 0.49 for Q4 2024, which was down 4466.97% from 0.88 recorded in Q4 2023.
- AC Immune's Equity Ratio's 5-year high stood at 0.91 during Q4 2022, with a 5-year trough of 0.49 in Q4 2024.
- Its 5-year average for Equity Ratio is 0.81, with a median of 0.89 in 2021.
- Its Equity Ratio has fluctuated over the past 5 years, first surged by 242.92% in 2022, then tumbled by 4466.97% in 2024.
- AC Immune's Equity Ratio (Quarter) stood at 0.9 in 2020, then fell by 1.69% to 0.89 in 2021, then grew by 2.43% to 0.91 in 2022, then fell by 3.32% to 0.88 in 2023, then tumbled by 44.67% to 0.49 in 2024.
- Its Equity Ratio stands at 0.49 for Q4 2024, versus 0.88 for Q4 2023 and 0.91 for Q4 2022.